CaviWipes™ 2.0 XL are next-generation, extra-large disinfectant wipes engineered to meet today’s most demanding infection prevention standards. Building on decades of clinical trust, CaviWipes 2.0 deliver universal 2-minute contact time efficacy against all 60 listed pathogens, including SARS-CoV-2, Norovirus, and Candida auris, helping reduce the risk of healthcare-associated infections.
Formulated with a neutral pH for excellent material compatibility, CaviWipes 2.0 XL are safe for use on most hard, non-porous surfaces commonly found in clinical, laboratory, and emergency care environments. These durable, non-woven 9” x 12” towelettes provide superior surface coverage, improving cleaning efficiency while reducing wipe usage.
CaviWipes 2.0 qualify for all levels of the EPA’s Emerging Viral Pathogens (EVP) Claim and are listed on EPA List Q, covering enveloped, large non-enveloped, and small non-enveloped viruses. The redesigned, easy-to-read label allows staff to quickly identify efficacy claims, compatibility, and critical safety information, supporting compliance and confident use during both routine operations and emerging public health events.
Kill Claims Summary (2-Minute Efficacy)
Non-Enveloped Viruses
• Adenovirus Type 2, Type 5
• Echovirus Type 11
• Enterovirus Type 71
• Human Rotavirus
• Norovirus
• Rhinovirus Type 1A
Pathogenic Fungi
• Candida auris
Multi-Drug Resistant Bacteria
• MRSA
• VRE
• VISA
• PRSP
• CRKP
• MRAB
• ESBL Klebsiella pneumoniae
• ESBL Escherichia coli
• NDM-1 Enterobacter cloacae
• MDR Pseudomonas aeruginosa
• Methicillin-Resistant Staphylococcus epidermidis
Bacteria
• Acinetobacter baumannii
• Bordetella pertussis
• Burkholderia cepacia
• Campylobacter jejuni
• Chlamydophila pneumoniae
• Escherichia coli O157:H7
• Klebsiella aerogenes
• Klebsiella pneumoniae
• Legionella pneumophila
• Listeria monocytogenes
• Mycobacterium tuberculosis (TB)
• Pseudomonas aeruginosa
• Salmonella enterica
• Serratia marcescens
• Shigella dysenteriae
• Staphylococcus aureus
• Stenotrophomonas maltophilia
• Streptococcus mutans
• Streptococcus pyogenes
Enveloped Viruses
• SARS-CoV-2 (including UK, South African, California, Delta variants)
• SARS-associated Coronavirus
• Influenza A & B
• Hepatitis B Virus (HBV)
• Hepatitis C Virus (HCV)
• HIV-1
• Herpes Simplex Virus Types 1 & 2
• Varicella-zoster virus
• Cytomegalovirus
• Parainfluenza Virus Type 3
• Human orthopneumovirus
• Measles virus
Recommended Uses
Designed for use in:
• Hospitals and operating rooms
• Emergency medical services and vehicles
• Laboratories and isolation areas
• Dental and surgical centers
• Neonatal and infant care units
• Nursing homes and outpatient facilities
• Schools, daycare centers, and correctional facilities
• Animal care and veterinary environments